Generated: April 23, 2017
|Title:||Method for the prevention and control of epileptic seizure associated with Lennox-Gastaut syndrome|
|Abstract:||A novel method for the prevention and control of epileptic seizures, particularly intractable seizures associated with the Lennox-Gastaut syndrome, employing pharmaceutical compositions containing 2-phenyl-1,3-propanediol dicarbamate.|
|Inventor(s):||Sofia; Robert D. (Willingboro, NJ)|
|Assignee:||Carter-Wallace, Inc. (New York, NY)|
|Filing Date:||Oct 26, 1992|
|Claims:||1. A method for the prevention and control of seizures associated with Lennox-Gastaut syndrome which comprises administering to a warm-blooded animal in need of such treatment 2-phenyl-1,3-propanediol dicarbamate in a daily dosage of from about 100 milligrams to about 5 grams.|
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.